AZN β€” ASTRAZENECA-ADR

Ownership history in MARSHALL WACE, LLP  Β·  36 quarters on record

This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in ASTRAZENECA-ADR (AZN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.8% (2019 Q2)
πŸ“Š Avg. % of fund
0.16%
πŸ“… First filed
2014 Q1
πŸ“… Last filed
2025 Q4
⏱ Quarters held
36

Position Intelligence

MARSHALL WACE, LLP Γ— AZN AI Analytics

πŸ“‰ MARSHALL WACE, LLP underperformed the S&P 500 by –6.8% annually on this AZN position. Timing score: 69% (24/35 decisions correct). Average cost basis: $106.55. Maximum drawdown during holding period: –18.8%.

πŸ“ˆ Position Alpha vs SPY
-6.8%
annualised excess return

❌ Significantly underperformed the S&P 500 by 6.8% ann.
11 quarters analyzed

⏱️ Timing Score
69%

βœ… Decent timing β€” more right than wrong on entries and exits.
24 of 35 add/trim decisions correct

πŸ’° Entry Quality
$106.55
+70.8% vs current ($181.96)

Best entry: $41.59 (2016 Q4)  Β·  Worst: $151.86 (2025 Q3)

πŸ›‘οΈ Drawdown Resilience
–18.8%
max drawdown while held

πŸ’Ž No drawdown exceeding 20% during the holding period β€” exceptionally stable.

πŸ’ͺ Fund Conviction
47%
buy-side decisions

17 adds Β· 19 trims. Bought during 6 of 12 down-price quarters. πŸ“‰ Predominantly trimming β€” distribution phase.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    AZN price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 10 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 10,920 -685,574 -98.4% 0.00% $1.0M $181.96
2025 Q3 ADDED 696,494 +696,394 +696394.0% 0.05% $53.4M $151.86
2025 Q3 REDUCED 100 -1,999,831 -100.0% 0.00% $8K $151.86
2025 Q2 ADDED 1,999,931 +623,902 +45.3% 0.16% $139.8M $137.36
2025 Q1 REDUCED 1,376,029 -2,500,932 -64.5% 0.13% $101.1M $144.48
2024 Q4 ADDED 3,876,961 +3,289,601 +560.1% 0.31% $254.0M $126.98
2024 Q2 REDUCED 587,360 -558,277 -48.7% 0.06% $45.8M $150.22
2024 Q1 ADDED 1,145,637 +1,104,864 +2709.8% 0.12% $77.6M $130.50
2023 Q4 ADDED 40,773 +8,372 +25.8% 0.00% $2.7M $127.76
2023 Q3 REDUCED 32,401 -200,513 -86.1% 0.00% $2.2M $128.47
26 older quarters hidden  β€”  Sign in free or upgrade to Premium to see full history

🏒 Other funds also holding AZN

As of 2025 Q4 β€” sorted by position size

Foresight Global Investors, Inc. 25.0% SALT Holding Corp. 13.29% Martin Investment Management, LLC 3Y 7Y 7.96% Sofinnova Investments, Inc. 3Y 7Y 6.47% BOONE CAPITAL MANAGEMENT LLC 3Y 6.35% Act Two Investors LLC 3Y 7Y 5.82% CIDEL ASSET MANAGEMENT INC 3Y 7Y 3.66% PROFESSIONAL ADVISORY SERVICES INC 3Y 7Y 3.64% OAK FAMILY ADVISORS, LLC 3Y 3.64% Cox Capital Mgt LLC 3Y 7Y 3.45%
← Back to MARSHALL WACE, LLP Holdings